Zdrowie i gospodarka · 24/02/2012

FDA Releases Draft Guidance for Industry on Developing Drugs for Complicated Urinary Tract Infections

The Food and Drug Administration (FDA) has made available a draft guidance document to help pharmaceutical companies develop effective treatments for complicated urinary tract infections (cUTIs), outlining the agency's current thinking on clinical trial designs and overall drug development programs for this condition.